Triple-Negative Breast Cancer Research

Triple-Negative Breast Cancer (TNBC) represents one of the most aggressive and clinically challenging subtypes of breast cancer, accounting for approximately 15–20% of all breast cancer diagnoses. Characterized by the absence of estrogen receptors (ER), progesterone receptors (PR), and HER2 amplification, TNBC does not respond to most endocrine or HER2-targeted therapies, leaving chemotherapy and newer systemic treatments as the main therapeutic approaches. TNBC is highly diverse at the molecular level. Researchers will present updates on intrinsic subtypes such as basal-like, mesenchymal, and luminal androgen receptor (LAR), each with distinct genetic and signalling features. Understanding these subtypes has major implications for prognosis and targeted treatment. The use of PARP inhibitors for patients with BRCA1/2 mutations will also be covered. These agents exploit defects in DNA repair mechanisms to selectively kill cancer cells, offering a more targeted approach for genetically defined TNBC populations. Current strategies combining PARP inhibitors with chemotherapy or immunotherapy will be evaluated, along with discussions on resistance mechanisms and sequencing options. 

    Related Conference of Triple-Negative Breast Cancer Research

    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Paris, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    October 22-23, 2025

    4th Experts Meeting on Cancer Medicine, Radiology & Treatment

    Paris, France
    October 22-23, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    October 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    Zurich, Switzerland
    November 20-21, 2025

    38th Conference on Preventive Oncology and Diagnostic Cancer

    Rome, Italy
    November 20-21, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    November 24-25, 2025

    16th International Conference on Cancer Stem Cell & Oncology Research

    Barcelona, Spain
    November 24-25, 2025

    47th Euro-Global Summit on Cancer Therapy & Radiation Oncology

    Paris, France
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain
    December 08-09, 2025

    13th Euro Breast Cancer and Therapeutics

    Aix-en-Provence, France
    February 05-06, 2026

    11th World Conference on Breast and Cervical Cancer

    Paris, France
    February 12-13, 2026

    4th World Congress on Oral Cancer

    Singapore City, Singapore
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 23-24, 2026

    16th World Congress on Breast Cancer Research & Therapies

    Aix-en-Provence, France
    April 13-14, 2026

    23rd International Conference on Breast Pathology and Cancer Diagnosis

    Tokyo, Japan
    May 11-12, 2026

    4th International Conference on Cancer Biology and Therapeutics

    Rome, Italy
    June 18-19, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    June 22-23, 2026

    16th World Congress on Breast Cancer

    Dubai, UAE
    June 22-23, 2026

    46th Euro Congress on Cancer Science & Therapy

    Dubai, UAE
    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy

    Triple-Negative Breast Cancer Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in